At IQVIA, we continue to be committed to the global effort to proactively fight COVID-19 and to provide pharmaceutical companies with new commercial strategies and insight, purpose-built for today's evolving marketplace.
For many global pharmaceutical companies, 2021 was another year spent navigating the myriad market implications driven by the perpetuation of the pandemic. IQVIA's Quarterly COVID-19 EU4 & UK webinar explores a year-in-review of the impact of the COVID-19 pandemic on pharmaceutical markets.
On 30th March, IQVIA experts, Sarah Rickwood, VP, European Thought Leadership & Marketing and Natalie Harb, Practice Leader - Performance Management, Global Analytics & Consulting Solutions will explore:
Register now and join us for this live and dynamic webinar.
Discover actionable brand insights at the intersection of market research and advanced analytics.
Be proactive about growing your brand using the latest in data, analytics, and domain expertise.
Take advantage of the latest tools, techniques, and deep healthcare expertise to create scalable resources, precision insights, and actionable ideas.
